Comparable monthly disclosures
Institutional Activity
Where disclosed mutual fund positions are increasing, reducing, opening or closing.
Portfolio increases
Dec 2024 · Ranked across companies with at least 10 comparable portfolios
| Company | Portfolio increases | Comparable change | Portfolios increasing | Portfolios reducing | Comparable portfolios |
|---|---|---|---|---|---|
| GE Vernova T&D India Limited GVT&D | 24 21.8% of comparable | -0.08 Cr | 24 | 15 | 110 |
| Page Industries Limited PAGEIND | 24 25.5% of comparable | -12,155 | 24 | 15 | 94 |
| Ambuja Cements Limited AMBUJACEM | 24 24.0% of comparable | -0.01 Cr | 24 | 23 | 100 |
| Torrent Pharmaceuticals Limited TORNTPHARM | 24 24.5% of comparable | +0.02 Cr | 24 | 28 | 98 |
| Indian Railway Finance Corporation Limited IRFC | 23 67.6% of comparable | +0.82 Cr | 23 | 6 | 34 |
| Emami Limited EMAMILTD | 23 39.0% of comparable | -0.03 Cr | 23 | 6 | 59 |
| Life Insurance Corporation Of India LICI | 23 42.6% of comparable | +0.09 Cr | 23 | 12 | 54 |
| Indraprastha Gas Limited IGL | 23 38.3% of comparable | +1.07 Cr | 23 | 13 | 60 |
| Biocon Limited BIOCON | 23 37.1% of comparable | +0.43 Cr | 23 | 15 | 62 |
| BSE Limited BSE | 23 27.1% of comparable | +0.07 Cr | 23 | 20 | 85 |
| L&T Technology Services Limited LTTS | 23 30.7% of comparable | -0.02 Cr | 23 | 23 | 75 |
| Persistent Systems Limited PERSISTENT | 23 18.3% of comparable | +0.09 Cr | 23 | 43 | 126 |
| Adani Total Gas Limited ATGL | 22 71.0% of comparable | +0.14 Cr | 22 | 3 | 31 |
| GUJARAT ENERGY LIMITED GUJENERGY | 22 42.3% of comparable | +0.11 Cr | 22 | 7 | 52 |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO | 22 50.0% of comparable | +52,771 | 22 | 8 | 44 |
| BIRLASOFT LIMITED BSOFT | 22 40.0% of comparable | -0.04 Cr | 22 | 8 | 55 |
| Aditya Birla Fashion and Retail Limited ABFRL | 22 40.0% of comparable | +0.29 Cr | 22 | 9 | 55 |
| APL Apollo Tubes Limited APLAPOLLO | 22 30.1% of comparable | -745 | 22 | 10 | 73 |
| Balkrishna Industries Limited BALKRISIND | 22 35.5% of comparable | +0.06 Cr | 22 | 13 | 62 |
| Glenmark Pharmaceuticals Limited GLENMARK | 22 33.8% of comparable | +0.07 Cr | 22 | 13 | 65 |
| Jubilant Foodworks Limited JUBLFOOD | 22 18.8% of comparable | +0.12 Cr | 22 | 16 | 117 |
| Syngene International Limited SYNGENE | 22 30.6% of comparable | +0.06 Cr | 22 | 19 | 72 |
| Divi's Laboratories Limited DIVISLAB | 22 17.2% of comparable | +39,772 | 22 | 36 | 128 |
| MRF Limited MRF | 21 40.4% of comparable | +6,094 | 21 | 6 | 52 |
| Dalmia Bharat Limited DALBHARAT | 21 40.4% of comparable | +0.06 Cr | 21 | 8 | 52 |
How to read this activity
Activity compares disclosed positions for economic portfolios observed in both relevant monthly disclosures and adjusts for externally evidenced corporate actions where available.
At least 10 comparable portfolios are required. Companies under corporate-action review are excluded. Counts are unweighted by portfolio size, and share changes are quantities rather than market values; zero counts can appear at the end of a ranking. Breadth change is the change in AMCs holding, and can also reflect reporting coverage.
Full methodology →